Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.38 billion.
Market Cap
1.12T
Revenue
105.38B
Profits
-41.41B
PE Ratio
n/a
Profit Margin
-39.29%
Dividend Yield
0.04%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.76B | 0.45% | 759,615 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.46B | 1.83% | 692,565 | 14.34B |
| 3 | ARGX | argenx SE | 51.17B | -0.57% | 243,316 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.80B | 0.31% | 1,910,916 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.18B | 1.36% | 365,115 | 4.97B |
| 6 | INSM | Insmed Incorporated | 32.84B | -1.84% | 2,612,196 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.32B | -4.28% | 1,056,138 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 24.45B | 1.63% | 3,864,065 | 2.35B |
| 9 | GMAB | Genmab A/S | 20.35B | 1.96% | 880,303 | 3.85B |
| 10 | INCY | Incyte Corporation | 20.16B | 2.60% | 1,573,729 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.78B | 0.22% | 2,540,128 | - |
| 12 | MRNA | Moderna, Inc. | 16.63B | -3.45% | 16,100,919 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.26B | 1.48% | 8,931,711 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.08B | 1.26% | 1,291,513 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.71B | -1.22% | 300,196 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.46B | 0.48% | 1,783,021 | 966.96M |
| 17 | EXEL | Exelixis, Inc. | 11.52B | 3.51% | 4,145,666 | 2.29B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.13B | 2.49% | 1,863,238 | 3.09B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.12B | 0.09% | 256,791 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.96B | 0.23% | 1,402,594 | 20.87M |
| 21 | SMMT | Summit Therapeutics Inc. | 10.84B | -2.90% | 2,725,180 | - |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.22B | 5.29% | 1,950,357 | 829.45M |
| 23 | TECH | Bio-Techne Corporation | 10.17B | 1.81% | 3,249,733 | 1.22B |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 10.17B | 1.70% | 786,665 | 4.16B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.37B | 0.88% | 572,900 | 561.26M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.76B | 3.82% | 2,076,456 | 1.24B |
| 27 | ABVX | ABIVAX Société Anonyme | 8.61B | 0.28% | 749,868 | 6.23M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.57B | -1.56% | 587,530 | 7.46M |
| 29 | KRYS | Krystal Biotech, Inc. | 8.19B | 1.09% | 218,997 | 373.16M |
| 30 | PCVX | Vaxcyte, Inc. | 8.15B | 7.15% | 3,551,801 | - |
| 31 | NUVL | Nuvalent, Inc. | 8.14B | 1.90% | 500,279 | - |
| 32 | CYTK | Cytokinetics, Incorporated | 7.97B | 3.12% | 1,346,421 | 87.21M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.27B | 6.31% | 635,200 | 174.33M |
| 34 | CAI | Caris Life Sciences, Inc. | 6.58B | 0.69% | 2,711,676 | 649.06M |
| 35 | BLTE | Belite Bio, Inc | 6.50B | 2.55% | 117,415 | - |
| 36 | MIRM | Mirum Pharmaceuticals, Inc. | 6.22B | 0.56% | 903,360 | 471.79M |
| 37 | GPCR | Structure Therapeutics Inc. | 6.21B | 1.57% | 698,603 | - |
| 38 | KYMR | Kymera Therapeutics, Inc. | 6.05B | 4.03% | 606,878 | 43.74M |
| 39 | IBRX | ImmunityBio, Inc. | 6.04B | -1.92% | 24,280,178 | 82.56M |
| 40 | PTCT | PTC Therapeutics, Inc. | 6.01B | -0.86% | 1,548,621 | 1.78B |
| 41 | COGT | Cogent Biosciences, Inc. | 5.77B | 5.71% | 1,774,660 | - |
| 42 | IMVT | Immunovant, Inc. | 5.29B | 0.31% | 1,174,869 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.19B | 1.53% | 1,273,893 | 209.22M |
| 44 | CELC | Celcuity Inc. | 5.15B | 1.75% | 555,967 | - |
| 45 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.06B | -1.18% | 1,017,386 | 1.54M |
| 46 | CRSP | CRISPR Therapeutics AG | 4.89B | 2.70% | 1,710,724 | 38.34M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.75B | 5.12% | 1,013,657 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.43B | 0.18% | 919,609 | - |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.42B | 3.98% | 1,325,378 | 1.05B |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.42B | - | 7,773,865 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.38B | 4.40% | 639,840 | 2.17M |
| 52 | CORT | Corcept Therapeutics Incorporated | 4.28B | 2.11% | 2,249,977 | 741.17M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.27B | -0.85% | 1,923,767 | 531.90M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.16B | 1.16% | 1,964,439 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 4.03B | 1.90% | 582,873 | 35.90M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 4.00B | 6.42% | 1,565,585 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.90B | 3.03% | 152,370 | 251.23M |
| 58 | LQDA | Liquidia Corporation | 3.85B | 4.29% | 1,437,780 | 69.22M |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.68B | 2.52% | 1,046,209 | 15.00M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.58B | 1.45% | 489,081 | 35.24M |
| 61 | DNLI | Denali Therapeutics Inc. | 3.55B | 4.60% | 1,579,593 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.38B | 3.03% | 2,535,084 | - |
| 63 | ALMS | Alumis Inc. | 3.29B | 7.79% | 1,869,406 | 22.12M |
| 64 | ERAS | Erasca, Inc. | 3.28B | 0.95% | 7,148,772 | - |
| 65 | VERA | Vera Therapeutics, Inc. | 3.21B | 4.67% | 1,302,699 | - |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.20B | 1.07% | 649,354 | 7.50M |
| 67 | VRDN | Viridian Therapeutics, Inc. | 3.17B | 0.61% | 1,390,150 | 70.79M |
| 68 | LEGN | Legend Biotech Corporation | 3.17B | -2.00% | 2,109,051 | 909.05M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.13B | 0.79% | 1,443,157 | 317.93M |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.09B | 4.86% | 1,822,784 | - |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.07B | 2.88% | 1,221,627 | 578.20M |
| 72 | EWTX | Edgewise Therapeutics, Inc. | 3.06B | 2.63% | 603,346 | - |
| 73 | IRON | Disc Medicine, Inc. | 3.05B | 4.37% | 252,245 | - |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | 5.81% | 879,829 | 214.83M |
| 75 | TVTX | Travere Therapeutics, Inc. | 2.96B | 6.45% | 1,578,009 | 435.83M |
| 76 | APLS | Apellis Pharmaceuticals, Inc. | 2.89B | 1.11% | 2,804,904 | 1.02B |
| 77 | IMNM | Immunome, Inc. | 2.88B | 6.17% | 1,600,651 | 9.68M |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.81B | -0.59% | 2,249,031 | 252.75M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | 2.15% | 538,746 | 366.10M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.76B | 1.09% | 1,304,635 | 55.70M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.68B | 2.95% | 1,003,607 | 240.00M |
| 82 | SYRE | Spyre Therapeutics, Inc. | 2.54B | 2.41% | 442,455 | - |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.47B | 2.06% | 81,110 | 664.23M |
| 84 | WVE | Wave Life Sciences Ltd. | 2.46B | 3.79% | 2,542,835 | 109.23M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | -0.10% | 785,267 | - |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | 2.87% | 3,437,956 | 630.60M |
| 87 | DNTH | Dianthus Therapeutics, Inc. | 2.30B | -0.43% | 473,132 | 3.08M |
| 88 | SLNO | Soleno Therapeutics, Inc. | 2.27B | 9.75% | 2,469,247 | 98.68M |
| 89 | GLPG | Galapagos NV | 2.25B | 1.03% | 65,504 | 336.64M |
| 90 | MAZE | Maze Therapeutics, Inc. | 2.24B | 6.77% | 741,665 | 2.50M |
| 91 | MESO | Mesoblast Limited | 2.23B | -0.35% | 151,979 | 17.20M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | 3.61% | 472,904 | 825.94M |
| 93 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -0.24% | 17,377,090 | 43.69M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 1.87% | 1,869,736 | 2.41B |
| 95 | AAPG | Ascentage Pharma Group International | 2.14B | -4.18% | 1,790 | 54.52M |
| 96 | OLMA | Olema Pharmaceuticals, Inc. | 2.02B | -0.27% | 3,408,293 | - |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 4.75% | 1,185,812 | 265.81M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.95B | 0.11% | 4,865,518 | 55.78M |
| 99 | SION | Sionna Therapeutics, Inc. | 1.94B | 2.99% | 911,849 | - |
| 100 | NUVB | Nuvation Bio Inc. | 1.93B | 7.44% | 3,864,147 | 26.75M |
| 101 | ARDX | Ardelyx, Inc. | 1.89B | 1.30% | 2,654,300 | 398.23M |
| 102 | VCEL | Vericel Corporation | 1.87B | 2.67% | 335,017 | 258.72M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 5.12% | 1,372,446 | 111.30M |
| 104 | MNKD | MannKind Corporation | 1.85B | 3.98% | 4,614,324 | 313.79M |
| 105 | ZLAB | Zai Lab Limited | 1.81B | -1.81% | 1,417,101 | 441.63M |
| 106 | DFTX | Definium Therapeutics, Inc. | 1.80B | 8.00% | 2,054,719 | - |
| 107 | PHVS | Pharvaris N.V. | 1.78B | 1.55% | 175,155 | - |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 3.45% | 991,389 | 83.98M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.76B | 1.42% | 548,997 | 205.63M |
| 110 | CRVS | Corvus Pharmaceuticals, Inc. | 1.76B | 1.35% | 2,726,898 | - |
| 111 | MBX | MBX Biosciences, Inc. | 1.75B | 6.02% | 636,222 | - |
| 112 | ZYME | Zymeworks Inc. | 1.73B | 2.84% | 455,302 | 134.48M |
| 113 | PGEN | Precigen, Inc. | 1.71B | 7.57% | 2,495,134 | 6.31M |
| 114 | OCS | Oculis Holding AG | 1.68B | 2.04% | 293,154 | 992.00K |
| 115 | ELVN | Enliven Therapeutics, Inc. | 1.67B | 6.50% | 851,221 | - |
| 116 | RAPT | RAPT Therapeutics, Inc. | 1.67B | -0.01% | 2,951,825 | - |
| 117 | IMCR | Immunocore Holdings plc | 1.67B | 1.51% | 241,667 | 379.59M |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.66B | 0.20% | 482,721 | - |
| 119 | PLYX | Polaryx Therapeutics, Inc. | 1.66B | 243.14% | 24,517 | - |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.66B | 0.65% | 560,540 | - |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.65B | 1.75% | 1,118,375 | 181.54M |
| 122 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 2.62% | 874,575 | 44.79M |
| 123 | CLDX | Celldex Therapeutics, Inc. | 1.64B | 0.24% | 732,034 | 2.60M |
| 124 | UPB | Upstream Bio, Inc. | 1.62B | -3.64% | 782,998 | 2.80M |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.61B | 2.84% | 1,915,568 | 66.50M |
| 126 | INVA | Innoviva, Inc. | 1.57B | 4.90% | 921,861 | 388.52M |
| 127 | BHVN | Biohaven Ltd. | 1.56B | -0.68% | 2,445,772 | - |
| 128 | FTRE | Fortrea Holdings Inc. | 1.56B | 0.30% | 1,379,545 | 2.76B |
| 129 | QURE | uniQure N.V. | 1.54B | 8.71% | 2,587,597 | 15.75M |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -0.68% | 3,192,443 | 57.53M |
| 131 | KOD | Kodiak Sciences Inc. | 1.49B | 5.88% | 713,380 | - |
| 132 | RLAY | Relay Therapeutics, Inc. | 1.41B | 6.40% | 1,688,204 | 8.36M |
| 133 | NVAX | Novavax, Inc. | 1.41B | -1.75% | 3,318,184 | 1.06B |
| 134 | TRVI | Trevi Therapeutics, Inc. | 1.41B | 4.68% | 1,122,020 | - |
| 135 | ANAB | AnaptysBio, Inc. | 1.40B | 6.60% | 545,839 | 169.47M |
| 136 | ATAI | AtaiBeckley Inc. | 1.39B | 2.13% | 3,098,301 | 3.02M |
| 137 | IMTX | Immatics N.V. | 1.34B | 4.61% | 425,104 | 99.45M |
| 138 | DBVT | DBV Technologies S.A. | 1.33B | -0.46% | 247,099 | 5.50M |
| 139 | SVRA | Savara Inc. | 1.33B | 2.22% | 1,232,755 | - |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.33B | 4.58% | 207,926 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | 3.33% | 1,517,857 | 6.31M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.22B | 3.61% | 1,845,091 | - |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.22B | - | 1,549,522 | 266.14M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.20B | 7.81% | 202,440 | 1.40M |
| 145 | CAPR | Capricor Therapeutics, Inc. | 1.19B | 5.48% | 817,560 | 11.13M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.18B | 3.18% | 1,591,246 | 133.67M |
| 147 | CMPX | Compass Therapeutics, Inc. | 1.16B | 1.87% | 2,382,963 | 850.00K |
| 148 | IVA | Inventiva S.A. | 1.16B | -4.06% | 476,246 | 19.93M |
| 149 | PHAR | Pharming Group N.V. | 1.16B | -17.07% | 114,704 | 362.27M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.15B | 8.54% | 163,323 | 5.56M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.13B | 0.77% | 1,569,997 | - |
| 152 | SEPN | Septerna, Inc. | 1.12B | 7.24% | 487,831 | 22.05M |
| 153 | EYPT | EyePoint, Inc. | 1.10B | -1.70% | 1,898,222 | 42.34M |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 8.77% | 1,975,308 | - |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.08B | 1.02% | 546,439 | 147.19M |
| 156 | VIR | Vir Biotechnology, Inc. | 1.07B | 3.63% | 1,466,045 | 16.86M |
| 157 | ABCL | AbCellera Biologics Inc. | 1.05B | -3.31% | 6,137,823 | 35.33M |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 1.04B | 2.35% | 11,074,542 | 250.43M |
| 159 | CTMX | CytomX Therapeutics, Inc. | 1.03B | 7.03% | 4,323,805 | 113.63M |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 1.02B | 3.10% | 1,646,386 | 142.77M |
| 161 | NBTX | Nanobiotix S.A. | 1.02B | 1.76% | 35,017 | 11.93M |
| 162 | TBPH | Theravance Biopharma, Inc. | 1.00B | 4.70% | 319,122 | 80.33M |
| 163 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.07% | 5,046,581 | - |
| 164 | GERN | Geron Corporation | 983.07M | 12.41% | 27,145,514 | 183.40M |
| 165 | GHRS | GH Research PLC | 981.31M | 1.02% | 165,939 | - |
| 166 | ZBIO | Zenas BioPharma, Inc. | 974.28M | -1.20% | 854,840 | 15.00M |
| 167 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 962.26M | 2.65% | 153,973 | - |
| 168 | ANNX | Annexon, Inc. | 950.98M | 2.24% | 1,571,402 | - |
| 169 | PVLA | Palvella Therapeutics, Inc. | 945.74M | 4.19% | 470,469 | - |
| 170 | AVBP | ArriVent BioPharma, Inc. | 935.85M | 0.80% | 529,146 | - |
| 171 | URGN | UroGen Pharma Ltd. | 922.14M | 0.46% | 455,768 | 96.52M |
| 172 | BCAX | Bicara Therapeutics Inc. | 918.15M | -0.24% | 274,382 | - |
| 173 | ARVN | Arvinas, Inc. | 888.22M | 3.36% | 785,020 | 312.30M |
| 174 | XNCR | Xencor, Inc. | 864.78M | 0.17% | 584,744 | 150.13M |
| 175 | MRVI | Maravai LifeSciences Holdings, Inc. | 863.01M | 0.45% | 741,634 | 192.44M |
| 176 | ABUS | Arbutus Biopharma Corporation | 844.30M | 6.30% | 5,293,532 | 14.61M |
| 177 | JANX | Janux Therapeutics, Inc. | 841.47M | 2.04% | 1,088,776 | 10.00M |
| 178 | OMER | Omeros Corporation | 830.95M | 0.26% | 1,170,321 | - |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 814.30M | 3.20% | 539,627 | 1.43M |
| 180 | VALN | Valneva SE | 799.94M | 0.87% | 6,098 | 211.09M |
| 181 | YDES | YD Bio Limited | 795.32M | -4.72% | 42,841 | 510.36K |
| 182 | MPLT | MapLight Therapeutics, Inc. | 782.49M | 1.36% | 162,913 | - |
| 183 | NKTR | Nektar Therapeutics | 775.42M | 2.12% | 590,420 | 62.60M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 771.09M | 1.54% | 165,682 | - |
| 185 | JBIO | Jade Biosciences, Inc. | 765.97M | 6.66% | 221,311 | - |
| 186 | MDXG | MiMedx Group, Inc. | 753.84M | -0.39% | 1,172,128 | 393.44M |
| 187 | CGEM | Cullinan Therapeutics, Inc. | 750.86M | 6.27% | 941,100 | - |
| 188 | GYRE | Gyre Therapeutics, Inc. | 746.21M | 1.48% | 133,170 | 107.27M |
| 189 | KURA | Kura Oncology, Inc. | 719.63M | 1.85% | 986,017 | 104.03M |
| 190 | FULC | Fulcrum Therapeutics, Inc. | 707.20M | -0.09% | 496,736 | 80.00M |
| 191 | ALT | Altimmune, Inc. | 695.03M | -0.89% | 5,171,084 | 20.00K |
| 192 | SLS | SELLAS Life Sciences Group, Inc. | 676.02M | 5.31% | 5,569,952 | - |
| 193 | PRME | Prime Medicine, Inc. | 672.74M | -0.26% | 2,793,177 | 5.98M |
| 194 | ENGN | enGene Holdings Inc. | 669.85M | 4.93% | 295,154 | - |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 653.63M | 3.30% | 217,605 | 282.08M |
| 196 | CRMD | CorMedix Inc. | 643.71M | 5.28% | 3,483,774 | 214.30M |
| 197 | MGTX | MeiraGTx Holdings plc | 629.04M | 2.69% | 490,377 | 27.42M |
| 198 | FBRX | Forte Biosciences, Inc. | 615.01M | 17.83% | 357,529 | - |
| 199 | PROK | ProKidney Corp. | 613.70M | 3.03% | 495,913 | 744.00K |
| 200 | EVMN | Evommune, Inc. | 606.21M | 6.24% | 262,151 | 13.00M |
| 201 | DRTS | Alpha Tau Medical Ltd. | 593.44M | 0.29% | 233,146 | - |
| 202 | DSGN | Design Therapeutics, Inc. | 592.99M | 1.96% | 245,688 | - |
| 203 | LBRX | LB Pharmaceuticals Inc | 579.60M | 6.81% | 190,895 | - |
| 204 | GOSS | Gossamer Bio, Inc. | 574.01M | 8.77% | 8,761,098 | 44.05M |
| 205 | KROS | Keros Therapeutics, Inc. | 560.58M | 2.74% | 277,200 | 246.72M |
| 206 | LXEO | Lexeo Therapeutics, Inc. | 557.62M | 3.10% | 526,757 | - |
| 207 | REPL | Replimune Group, Inc. | 547.14M | -0.78% | 751,486 | - |
| 208 | RGNX | REGENXBIO Inc. | 545.72M | -3.41% | 817,198 | 161.32M |
| 209 | ZVRA | Zevra Therapeutics, Inc. | 527.79M | 4.17% | 1,073,974 | 84.39M |
| 210 | LYEL | Lyell Immunopharma, Inc. | 526.21M | 3.21% | 69,596 | 41.00K |
| 211 | TENX | Tenax Therapeutics, Inc. | 525.39M | 3.52% | 248,221 | - |
| 212 | CTNM | Contineum Therapeutics, Inc. | 525.29M | 0.84% | 383,692 | - |
| 213 | LXRX | Lexicon Pharmaceuticals, Inc. | 522.33M | 7.76% | 3,914,989 | 70.86M |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 520.62M | 2.12% | 877,985 | 180.61M |
| 215 | LENZ | LENZ Therapeutics, Inc. | 510.03M | 3.03% | 1,929,392 | 17.50M |
| 216 | SLDB | Solid Biosciences Inc. | 500.96M | -0.46% | 1,011,874 | - |
| 217 | VOR | Vor Biopharma Inc. | 495.23M | -1.62% | 863,395 | - |
| 218 | ANRO | Alto Neuroscience, Inc. | 491.16M | 2.13% | 245,018 | - |
| 219 | IVVD | Invivyd, Inc. | 490.66M | - | 3,904,885 | 50.04M |
| 220 | NAGE | Niagen Bioscience, Inc. | 487.74M | 1.67% | 791,260 | 124.71M |
| 221 | ADCT | ADC Therapeutics SA | 483.12M | 8.03% | 713,206 | 75.21M |
| 222 | VSTM | Verastem, Inc. | 482.39M | 2.46% | 1,254,018 | 13.38M |
| 223 | PRTA | Prothena Corporation plc | 479.63M | 1.14% | 556,552 | 11.79M |
| 224 | KYTX | Kyverna Therapeutics, Inc. | 475.89M | 4.00% | 689,299 | - |
| 225 | VTVT | vTv Therapeutics Inc. | 475.38M | 8.19% | 30,280 | 17.00K |
| 226 | OCGN | Ocugen, Inc. | 468.88M | -1.38% | 3,331,031 | 5.37M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 466.72M | 3.27% | 767,124 | 120.00K |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 457.41M | 2.65% | 956,540 | 212.07M |
| 229 | ABSI | Absci Corporation | 454.12M | 1.00% | 2,491,994 | 2.82M |
| 230 | BCYC | Bicycle Therapeutics plc | 450.20M | 1.09% | 176,916 | 28.34M |
| 231 | PRTC | PureTech Health plc | 447.40M | -1.12% | 246 | 6.39M |
| 232 | GLSI | Greenwich LifeSciences, Inc. | 442.93M | 6.32% | 251,703 | - |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 439.08M | 1.93% | 128,174 | - |
| 234 | MNPR | Monopar Therapeutics Inc. | 437.58M | 8.45% | 267,661 | - |
| 235 | TRDA | Entrada Therapeutics, Inc. | 424.96M | 3.58% | 194,709 | 61.52M |
| 236 | BNTC | Benitec Biopharma Inc. | 421.92M | 2.30% | 106,796 | - |
| 237 | TECX | Tectonic Therapeutic, Inc. | 421.49M | 12.66% | 427,440 | - |
| 238 | ALLO | Allogene Therapeutics, Inc. | 420.25M | 1.63% | 11,399,059 | 22.00K |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.07M | -4.83% | 44,275 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 417.10M | 2.31% | 68,729 | 37.19M |
| 241 | IMMP | Immutep Limited | 415.49M | 4.76% | 147,478 | 3.31M |
| 242 | AVXL | Anavex Life Sciences Corp. | 403.85M | -3.83% | 1,391,644 | - |
| 243 | NBP | NovaBridge Biosciences | 395.45M | 3.63% | 895,111 | - |
| 244 | ACRS | Aclaris Therapeutics, Inc. | 391.13M | 2.85% | 1,758,170 | 15.74M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 382.75M | 2.25% | 176,075 | 65.32M |
| 246 | TARA | Protara Therapeutics, Inc. | 377.25M | -0.56% | 530,274 | - |
| 247 | RCKT | Rocket Pharmaceuticals, Inc. | 376.61M | - | 1,341,948 | - |
| 248 | ZURA | Zura Bio Limited | 375.18M | 1.58% | 213,986 | - |
| 249 | AURA | Aura Biosciences, Inc. | 373.40M | 5.00% | 281,067 | - |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 373.18M | 4.05% | 1,206,178 | 10.82M |
| 251 | AUTL | Autolus Therapeutics plc | 367.28M | 0.73% | 1,123,842 | 51.13M |
| 252 | PEPG | PepGen Inc. | 349.24M | -0.97% | 383,956 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 348.00M | 7.57% | 385,605 | 33.98M |
| 254 | PBYI | Puma Biotechnology, Inc. | 343.67M | 5.25% | 471,161 | 212.00M |
| 255 | HELP | Cybin Inc. | 342.84M | 3.78% | 587,070 | - |
| 256 | FHTX | Foghorn Therapeutics Inc. | 342.70M | 2.45% | 148,539 | 24.52M |
| 257 | ANL | Adlai Nortye Ltd. | 342.07M | -12.79% | 785,903 | -1.35M |
| 258 | NMRA | Neumora Therapeutics, Inc. | 336.48M | -0.50% | 509,471 | - |
| 259 | XOMA | XOMA Royalty Corporation | 328.36M | 3.34% | 384,924 | 47.11M |
| 260 | IMMX | Immix Biopharma, Inc. | 327.24M | 6.52% | 699,318 | - |
| 261 | ALDX | Aldeyra Therapeutics, Inc. | 326.68M | 1.31% | 355,983 | - |
| 262 | ACIU | AC Immune SA | 323.54M | 2.51% | 147,703 | 5.48M |
| 263 | CADL | Candel Therapeutics, Inc. | 322.25M | 0.51% | 418,987 | - |
| 264 | AVIR | Atea Pharmaceuticals, Inc. | 317.98M | -4.01% | 750,955 | - |
| 265 | IMRX | Immuneering Corporation | 311.23M | 4.10% | 1,115,854 | - |
| 266 | RZLT | Rezolute, Inc. | 300.44M | -2.99% | 3,022,935 | - |
| 267 | LRMR | Larimar Therapeutics, Inc. | 300.42M | -0.85% | 727,319 | - |
| 268 | AVTX | Avalo Therapeutics, Inc. | 289.72M | 3.57% | 807,675 | 192.00K |
| 269 | AARD | Aardvark Therapeutics, Inc. | 289.58M | 2.39% | 151,851 | - |
| 270 | NGNE | Neurogene Inc. | 283.93M | 3.79% | 129,930 | 925.00K |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 281.79M | 15.52% | 45,126 | 5.05M |
| 272 | CLLS | Cellectis S.A. | 280.44M | 0.79% | 12,764 | 82.55M |
| 273 | ABEO | Abeona Therapeutics Inc. | 280.17M | 1.57% | 756,459 | 400.00K |
| 274 | RLMD | Relmada Therapeutics, Inc. | 280.13M | 7.61% | 715,638 | - |
| 275 | FENC | Fennec Pharmaceuticals Inc. | 267.42M | 3.16% | 133,944 | 38.79M |
| 276 | CHRS | Coherus Oncology, Inc. | 262.29M | 0.46% | 1,799,012 | 277.73M |
| 277 | OABI | OmniAb, Inc. | 257.68M | -1.65% | 508,843 | 21.09M |
| 278 | HRTX | Heron Therapeutics, Inc. | 254.87M | 5.30% | 932,174 | 155.10M |
| 279 | NAUT | Nautilus Biotechnology, Inc. | 253.87M | 3.08% | 101,060 | - |
| 280 | ENLV | Enlivex Therapeutics Ltd. | 246.88M | 2.97% | 250,774 | - |
| 281 | STTK | Shattuck Labs, Inc. | 243.63M | -0.52% | 292,910 | 1.00M |
| 282 | CABA | Cabaletta Bio, Inc. | 240.66M | -2.72% | 2,694,192 | - |
| 283 | PALI | Palisade Bio, Inc. | 239.90M | 8.05% | 2,645,790 | - |
| 284 | MDWD | MediWound Ltd. | 232.32M | -0.06% | 76,704 | 20.93M |
| 285 | SLN | Silence Therapeutics plc | 231.45M | 1.66% | 90,088 | 25.83M |
| 286 | ACHV | Achieve Life Sciences, Inc. | 228.91M | 2.87% | 451,178 | - |
| 287 | OBIO | Orchestra BioMed Holdings, Inc. | 226.99M | 15.19% | 488,677 | 2.82M |
| 288 | CLYM | Climb Bio, Inc. | 225.83M | 5.82% | 170,140 | - |
| 289 | VYGR | Voyager Therapeutics, Inc. | 222.40M | 2.56% | 686,299 | 31.32M |
| 290 | CNTX | Context Therapeutics Inc. | 217.75M | -9.20% | 2,662,065 | - |
| 291 | THAR | Tharimmune, Inc. | 216.62M | 12.07% | 3,415,361 | - |
| 292 | ALEC | Alector, Inc. | 216.12M | 4.76% | 849,853 | 69.05M |
| 293 | NBY | NovaBay Pharmaceuticals, Inc. | 215.76M | -8.06% | 983,407 | 10.30M |
| 294 | IKT | Inhibikase Therapeutics, Inc. | 214.75M | 4.67% | 551,670 | 1.00 |
| 295 | NVCT | Nuvectis Pharma, Inc. | 214.14M | 3.08% | 54,746 | - |
| 296 | TNXP | Tonix Pharmaceuticals Holding Corp. | 213.26M | -0.17% | 269,410 | 10.30M |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 209.41M | -1.34% | 436,771 | 97.60M |
| 298 | PLX | Protalix BioTherapeutics, Inc. | 209.10M | 11.11% | 2,662,199 | 61.84M |
| 299 | SABS | SAB Biotherapeutics, Inc. | 208.52M | -0.23% | 522,971 | 114.70K |
| 300 | SGMT | Sagimet Biosciences Inc. | 202.61M | 9.88% | 829,006 | - |
| 301 | NERV | Minerva Neurosciences, Inc. | 202.52M | 15.27% | 190,879 | - |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 199.10M | 2.62% | 1,421,093 | - |
| 303 | HUMA | Humacyte, Inc. | 196.86M | 2.24% | 3,090,654 | 1.57M |
| 304 | OVID | Ovid Therapeutics Inc. | 196.58M | -3.21% | 1,799,538 | 6.61M |
| 305 | EDIT | Editas Medicine, Inc. | 196.21M | 1.01% | 1,544,349 | 46.38M |
| 306 | CAMP | Camp4 Therapeutics Corporation | 196.11M | 2.16% | 25,068 | 3.80M |
| 307 | TNYA | Tenaya Therapeutics, Inc. | 195.25M | 16.41% | 7,206,061 | - |
| 308 | GALT | Galectin Therapeutics Inc. | 194.06M | 6.36% | 269,343 | - |
| 309 | CBIO | Crescent Biopharma, Inc. | 191.98M | 2.40% | 147,981 | - |
| 310 | SGMO | Sangamo Therapeutics, Inc. | 191.10M | 6.05% | 7,123,095 | 32.88M |
| 311 | SRZN | Surrozen, Inc. | 189.43M | 2.58% | 90,500 | 3.60M |
| 312 | MENS | Jyong Biotech Ltd. | 184.56M | 1.69% | 293,711 | - |
| 313 | TLSA | Tiziana Life Sciences Ltd | 183.78M | -4.64% | 123,381 | - |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 183.17M | 2.38% | 48,017 | 18.97M |
| 315 | CCCC | C4 Therapeutics, Inc. | 182.20M | -1.05% | 851,008 | 30.11M |
| 316 | ELDN | Eledon Pharmaceuticals, Inc. | 180.92M | 3.64% | 584,547 | - |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 180.53M | - | 81,813 | 59.99K |
| 318 | RNAC | Cartesian Therapeutics, Inc. | 176.56M | -0.59% | 71,014 | 1.09M |
| 319 | IPHA | Innate Pharma S.A. | 171.43M | -0.55% | 7,222 | 14.84M |
| 320 | MOLN | Molecular Partners AG | 170.21M | 3.76% | 8,807 | 856.30K |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 170.19M | 2.48% | 15,967 | - |
| 322 | CGEN | Compugen Ltd. | 169.30M | -1.63% | 180,747 | 6.90M |
| 323 | PRLD | Prelude Therapeutics Incorporated | 167.27M | 9.73% | 119,310 | 10.50M |
| 324 | PRQR | ProQR Therapeutics N.V. | 163.29M | -4.32% | 792,122 | 18.86M |
| 325 | ZNTL | Zentalis Pharmaceuticals, Inc. | 162.52M | 3.29% | 820,129 | 26.87M |
| 326 | IPSC | Century Therapeutics, Inc. | 160.83M | -3.16% | 1,261,642 | 113.34M |
| 327 | IRD | Opus Genetics, Inc. | 160.00M | 0.43% | 493,762 | 14.63M |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 156.89M | -0.38% | 444,122 | - |
| 329 | NKTX | Nkarta, Inc. | 153.42M | -2.70% | 1,062,587 | - |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.42M | 0.12% | 155,616 | - |
| 331 | VXRT | Vaxart, Inc. | 146.38M | 5.20% | - | 148.20M |
| 332 | RANI | Rani Therapeutics Holdings, Inc. | 145.83M | -0.83% | 914,903 | 1.20M |
| 333 | BDTX | Black Diamond Therapeutics, Inc. | 144.72M | 2.01% | 630,630 | 70.00M |
| 334 | FATE | Fate Therapeutics, Inc. | 141.88M | 3.36% | 1,664,943 | 7.14M |
| 335 | ELTX | Elicio Therapeutics, Inc. | 141.55M | 6.58% | 339,490 | - |
| 336 | CBUS | Cibus, Inc. | 140.52M | 6.67% | 295,613 | 3.79M |
| 337 | CNTB | Connect Biopharma Holdings Limited | 139.20M | 3.75% | 28,349 | 762.00K |
| 338 | UNCY | Unicycive Therapeutics, Inc. | 138.62M | 8.04% | 580,381 | - |
| 339 | ADAG | Adagene Inc. | 138.57M | 6.91% | 326,985 | 103.20K |
| 340 | MCRB | Seres Therapeutics, Inc. | 137.05M | 1.54% | 52,592 | 351.00K |
| 341 | CRBU | Caribou Biosciences, Inc. | 136.46M | 3.55% | 1,128,024 | 9.30M |
| 342 | WHWK | Whitehawk Therapeutics, Inc. | 135.73M | 6.67% | 241,000 | 14.38M |
| 343 | ORMP | Oramed Pharmaceuticals Inc. | 135.33M | 0.89% | 150,274 | 2.00M |
| 344 | CDXS | Codexis, Inc. | 130.07M | 16.13% | 1,722,162 | 52.93M |
| 345 | STRO | Sutro Biopharma, Inc. | 128.64M | 1.00% | 104,368 | 105.65M |
| 346 | SPRO | Spero Therapeutics, Inc. | 125.24M | 1.83% | 277,114 | 40.55M |
| 347 | TTRX | Turn Therapeutics Inc. | 123.08M | 1.46% | 24,064 | - |
| 348 | KRRO | Korro Bio, Inc. | 122.90M | -2.10% | 142,787 | 7.37M |
| 349 | GNLX | Genelux Corporation | 120.90M | 2.63% | 123,590 | 8.00K |
| 350 | VRCA | Verrica Pharmaceuticals Inc. | 119.12M | 5.97% | 257,782 | 30.83M |
| 351 | VANI | Vivani Medical, Inc. | 117.39M | 5.76% | 434,903 | - |
| 352 | ACTU | Actuate Therapeutics, Inc. | 116.91M | 6.79% | 52,917 | - |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 116.80M | 4.29% | 1,612,465 | 182.34K |
| 354 | KPTI | Karyopharm Therapeutics Inc. | 115.54M | -3.22% | 297,830 | 142.53M |
| 355 | CRDF | Cardiff Oncology, Inc. | 115.19M | -2.29% | 1,221,268 | 501.00K |
| 356 | MGNX | MacroGenics, Inc. | 110.70M | -4.37% | 424,890 | 127.63M |
| 357 | ACOG | Alpha Cognition Inc. | 110.21M | 4.73% | 70,794 | 7.43M |
| 358 | ONCY | Oncolytics Biotech Inc. | 104.20M | -1.26% | 1,062,853 | - |
| 359 | ARTV | Artiva Biotherapeutics, Inc. | 102.60M | 7.46% | 219,118 | 251.00K |
| 360 | SEER | Seer, Inc. | 101.82M | -0.55% | 218,050 | 16.38M |
| 361 | CGTX | Cognition Therapeutics, Inc. | 100.63M | 4.59% | 738,270 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 99.18M | 1.94% | 206,540 | 3.99M |
| 363 | CSBR | Champions Oncology, Inc. | 99.04M | -2.44% | 1,991 | 58.42M |
| 364 | ANIX | Anixa Biosciences, Inc. | 98.13M | -3.29% | 225,146 | - |
| 365 | FBIO | Fortress Biotech, Inc. | 97.77M | 1.61% | 630,863 | 62.30M |
| 366 | AGEN | Agenus Inc. | 97.26M | 0.70% | 502,661 | 106.83M |
| 367 | DTIL | Precision BioSciences, Inc. | 95.81M | 0.51% | 95,287 | 698.00K |
| 368 | PYXS | Pyxis Oncology, Inc. | 95.26M | 5.52% | 783,689 | 2.82M |
| 369 | ATYR | aTyr Pharma, Inc. | 95.07M | 9.90% | 7,268,314 | 190.00K |
| 370 | DWTX | Dogwood Therapeutics, Inc. | 94.00M | 5.02% | 40,375 | - |
| 371 | SAVA | Cassava Sciences, Inc. | 93.72M | -2.51% | 562,623 | - |
| 372 | EQ | Equillium, Inc. | 91.95M | 6.34% | 1,112,146 | 4.39M |
| 373 | ALXO | ALX Oncology Holdings Inc. | 91.09M | -3.45% | 249,665 | - |
| 374 | EXOZ | eXoZymes, Inc. | 89.55M | 2.50% | 1,985 | -700.00 |
| 375 | SPRB | Spruce Biosciences, Inc. | 83.48M | 0.57% | 18,338 | 697.00K |
| 376 | MNOV | MediciNova, Inc. | 81.83M | -3.20% | 37,249 | 257.92K |
| 377 | PYPD | PolyPid Ltd. | 81.01M | 6.33% | 41,408 | - |
| 378 | ACET | Adicet Bio, Inc. | 80.65M | -0.13% | 107,994 | - |
| 379 | OKYO | OKYO Pharma Limited | 80.37M | 1.95% | 158,308 | - |
| 380 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.35M | 2.06% | 134,525 | 501.00K |
| 381 | IMUX | Immunic, Inc. | 78.65M | 4.62% | 1,052,010 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 78.09M | 5.33% | 3,391 | 7.41M |
| 383 | BMEA | Biomea Fusion, Inc. | 77.77M | -1.79% | 1,393,720 | - |
| 384 | HYFT | MindWalk Holdings Corp. | 75.64M | - | 252,040 | 19.02M |
| 385 | XBIT | XBiotech Inc. | 75.61M | -1.59% | 62,535 | - |
| 386 | IMA | ImageneBio, Inc. | 75.52M | -5.59% | 182,863 | 800.00K |
| 387 | MAIA | MAIA Biotechnology, Inc. | 74.24M | -19.50% | 1,476,841 | - |
| 388 | PLRX | Pliant Therapeutics, Inc. | 73.12M | -1.65% | 776,459 | - |
| 389 | ETHZ | ETHZilla Corporation | 73.01M | -10.49% | 529,787 | 4.11M |
| 390 | GUTS | Fractyl Health, Inc. | 72.44M | 2.67% | 14,303,860 | 3.00K |
| 391 | ANVS | Annovis Bio, Inc. | 71.56M | - | 246,190 | - |
| 392 | MREO | Mereo BioPharma Group plc | 68.82M | -1.70% | 5,054,992 | 500.00K |
| 393 | GANX | Gain Therapeutics, Inc. | 68.46M | -1.11% | 384,727 | - |
| 394 | KZIA | Kazia Therapeutics Limited | 67.01M | 4.95% | 114,389 | 1.20M |
| 395 | IFRX | InflaRx N.V. | 65.99M | 10.42% | 629,932 | 73.73K |
| 396 | BYSI | BeyondSpring Inc. | 64.15M | 1.30% | 34,114 | 1.88M |
| 397 | NRXP | NRx Pharmaceuticals, Inc. | 63.65M | 2.38% | 269,587 | 242.00K |
| 398 | ENTX | Entera Bio Ltd. | 60.99M | -2.92% | 84,603 | 124.00K |
| 399 | TVGN | Tevogen Bio Holdings Inc. | 59.79M | -2.30% | 674,202 | - |
| 400 | GRCE | Grace Therapeutics, Inc. | 58.18M | 3.58% | 81,319 | - |
| 401 | TCRX | TScan Therapeutics, Inc. | 57.88M | - | 526,686 | 8.42M |
| 402 | MGX | Metagenomi Therapeutics, Inc. | 57.82M | - | 232,999 | 30.91M |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 57.11M | 1.12% | 640,267 | - |
| 404 | NTRB | Nutriband Inc. | 56.53M | -2.92% | 7,263 | 2.28M |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 56.40M | -1.85% | 193,017 | - |
| 406 | ICCC | ImmuCell Corporation | 55.36M | 1.66% | 20,431 | 27.77M |
| 407 | INKT | MiNK Therapeutics, Inc. | 54.45M | -1.53% | 8,219 | - |
| 408 | RADX | Radiopharm Theranostics Limited | 54.28M | 1.98% | 78,758 | 8.20M |
| 409 | IBO | Impact BioMedical Inc. | 53.98M | 5.31% | 154,749 | 25.00K |
| 410 | ATHE | Alterity Therapeutics Limited | 53.24M | -1.89% | 6,757 | 3.57M |
| 411 | IBIO | iBio, Inc. | 51.72M | 9.52% | 1,477,089 | 500.00K |
| 412 | LPCN | Lipocine Inc. | 50.24M | 0.56% | 66,119 | 4.32M |
| 413 | TIL | Instil Bio, Inc. | 49.64M | 3.68% | 74,500 | - |
| 414 | ALGS | Aligos Therapeutics, Inc. | 48.99M | -1.34% | 80,888 | 2.65M |
| 415 | QTTB | Q32 Bio Inc. | 48.97M | 2.58% | 104,834 | - |
| 416 | OSTX | OS Therapies Incorporated | 48.95M | 2.21% | 607,345 | - |
| 417 | ATOS | Atossa Therapeutics, Inc. | 48.14M | - | 666,490 | - |
| 418 | NRXS | NeurAxis, Inc. | 47.09M | 4.49% | 43,044 | 3.36M |
| 419 | APLM | Apollomics, Inc. | 46.72M | 18.96% | 25,899 | 6.93M |
| 420 | ESLA | Estrella Immunopharma, Inc. | 45.82M | -2.68% | 48,015 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 45.55M | 2.47% | 10,247 | - |
| 422 | CVM | CEL-SCI Corporation | 45.41M | -6.90% | 74,208 | - |
| 423 | PDSB | PDS Biotechnology Corporation | 45.21M | -0.79% | 479,505 | - |
| 424 | CRVO | CervoMed Inc. | 45.06M | -5.44% | 68,326 | 6.16M |
| 425 | ABVC | ABVC BioPharma, Inc. | 44.55M | -6.44% | 76,684 | 797.92K |
| 426 | CING | Cingulate Inc. | 43.89M | 6.45% | 233,134 | - |
| 427 | GLTO | Galecto, Inc. | 43.70M | 4.29% | 30,650 | - |
| 428 | LONA | LeonaBio, Inc. | 43.41M | -1.90% | 44,772 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 42.81M | 6.09% | 19,746,368 | 5.26M |
| 430 | INMB | INmune Bio Inc. | 42.00M | -0.63% | 556,299 | 50.00K |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 41.94M | 7.02% | 192,888 | - |
| 432 | LITS | Lite Strategy, Inc. | 41.92M | -5.79% | 514,772 | - |
| 433 | VERU | Veru Inc. | 41.73M | 2.77% | 234,540 | 16.89M |
| 434 | JSPR | Jasper Therapeutics, Inc. | 41.14M | -0.68% | 257,883 | - |
| 435 | LSTA | Lisata Therapeutics, Inc. | 40.31M | -1.30% | 68,273 | 1.07M |
| 436 | XLO | Xilio Therapeutics, Inc. | 39.69M | -1.23% | 915,330 | 31.80M |
| 437 | ANEB | Anebulo Pharmaceuticals, Inc. | 39.33M | -8.84% | 151,062 | - |
| 438 | PASG | Passage Bio, Inc. | 38.65M | 5.74% | 59,415 | - |
| 439 | NXTC | NextCure, Inc. | 38.32M | 0.74% | 43,679 | - |
| 440 | GBIO | Generation Bio Co. | 38.06M | 0.89% | 142,777 | 15.27M |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 38.06M | 5.17% | 67,278 | 90.00K |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 37.43M | 0.50% | 55,791 | - |
| 443 | RNXT | RenovoRx, Inc. | 37.38M | -1.92% | 314,359 | 928.00K |
| 444 | ATRA | Atara Biotherapeutics, Inc. | 36.34M | -3.08% | 93,664 | 151.93M |
| 445 | CELU | Celularity Inc. | 36.05M | 2.46% | 16,826 | 40.58M |
| 446 | OKUR | OnKure Therapeutics, Inc. | 35.97M | 0.57% | 94,807 | - |
| 447 | HYPD | Hyperion DeFi, Inc. | 34.43M | 16.48% | 974,326 | 345.32K |
| 448 | LTRN | Lantern Pharma Inc. | 34.22M | -2.86% | 27,736 | - |
| 449 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 34.19M | 0.07% | 1,854,308 | - |
| 450 | RNTX | Rein Therapeutics Inc. | 33.91M | -0.77% | 28,543 | - |
| 451 | KYNB | Kyntra Bio, Inc. | 33.01M | 3.55% | 38,104 | 8.30M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 32.93M | 2.55% | 452,291 | 1.14M |
| 453 | PLUR | Pluri Inc. | 32.93M | -5.17% | 4,434 | 1.33M |
| 454 | OTLK | Outlook Therapeutics, Inc. | 32.34M | 0.07% | 807,675 | 1.41M |
| 455 | HURA | TuHURA Biosciences, Inc. | 31.51M | -3.03% | 20,335,817 | - |
| 456 | DYAI | Dyadic International, Inc. | 31.16M | -1.15% | 27,722 | 3.34M |
| 457 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.02M | -4.30% | 68,945 | - |
| 458 | CUE | Cue Biopharma, Inc. | 31.01M | 1.52% | 343,836 | 7.10M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 30.79M | 1.07% | 158,826 | - |
| 460 | ANTX | AN2 Therapeutics, Inc. | 30.69M | -0.88% | 166,583 | - |
| 461 | PMN | ProMIS Neurosciences, Inc. | 30.24M | -0.78% | 188,207 | - |
| 462 | SKYE | Skye Bioscience, Inc. | 29.81M | -7.92% | 1,389,537 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 29.36M | -1.51% | 18,713 | 14.97M |
| 464 | SER | Serina Therapeutics, Inc. | 29.01M | -16.31% | 661,941 | 116.00K |
| 465 | MRKR | Marker Therapeutics, Inc. | 28.51M | 6.87% | 286,936 | 4.69M |
| 466 | AEON | AEON Biopharma, Inc. | 27.87M | - | 142,877 | - |
| 467 | RLYB | Rallybio Corporation | 27.72M | 2.18% | 48,566 | 674.00K |
| 468 | PTN | Palatin Technologies, Inc. | 26.97M | 17.27% | 32,684 | 8.85M |
| 469 | BCTX | BriaCell Therapeutics Corp. | 26.93M | 3.95% | 179,828 | - |
| 470 | XCUR | Exicure, Inc. | 26.77M | 3.19% | 10,664 | 500.00K |
| 471 | SNTI | Senti Biosciences, Inc. | 26.55M | 1.00% | 207,368 | - |
| 472 | IGC | IGC Pharma, Inc. | 26.26M | 1.52% | 296,043 | 1.11M |
| 473 | EVAX | Evaxion A/S | 25.85M | -2.52% | 66,262 | 7.65M |
| 474 | DARE | Daré Bioscience, Inc. | 25.44M | -1.66% | 50,622 | -57.13K |
| 475 | BOLD | Boundless Bio, Inc. | 25.29M | -2.59% | 587,942 | - |
| 476 | PLRZ | Polyrizon Ltd. | 24.10M | 31.36% | 234,177 | - |
| 477 | CLGN | CollPlant Biotechnologies Ltd. | 23.38M | -3.17% | 4,454 | 2.48M |
| 478 | GNTA | Genenta Science S.p.A. | 23.08M | -0.13% | 245,777 | - |
| 479 | VTGN | Vistagen Therapeutics, Inc. | 22.89M | 3.82% | 526,361 | 721.00K |
| 480 | INTS | Intensity Therapeutics, Inc. | 22.03M | 0.30% | 587,744 | - |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 21.67M | 0.25% | 15,226 | 15.65M |
| 482 | NNVC | NanoViricides, Inc. | 21.14M | 1.55% | 162,840 | - |
| 483 | JUNS | Jupiter Neurosciences, Inc. | 20.31M | 11.78% | 201,717 | - |
| 484 | CASI | CASI Pharmaceuticals, Inc. | 20.14M | -3.91% | 22,962 | 26.85M |
| 485 | IOBT | IO Biotech, Inc. | 20.00M | -4.17% | 1,679,405 | - |
| 486 | KLTO | Klotho Neurosciences, Inc. | 19.78M | -0.77% | 654,789 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 19.71M | 1.06% | 276,396 | 522.00K |
| 488 | KTTA | Pasithea Therapeutics Corp. | 19.52M | -1.84% | 82,564 | - |
| 489 | INAB | IN8bio, Inc. | 19.14M | -0.51% | 49,037 | - |
| 490 | VYNE | VYNE Therapeutics Inc. | 19.01M | 0.90% | 353,160 | 524.00K |
| 491 | FBLG | FibroBiologics, Inc. | 18.87M | -14.50% | 1,498,322 | - |
| 492 | QNTM | Quantum BioPharma Ltd. | 17.95M | -7.42% | 123,813 | - |
| 493 | LNAI | Lunai Bioworks Inc. | 17.75M | -2.93% | 97,309 | - |
| 494 | ITRM | Iterum Therapeutics plc | 17.73M | 9.28% | 604,689 | 390.00K |
| 495 | ALLR | Allarity Therapeutics, Inc. | 16.74M | -3.59% | 309,125 | - |
| 496 | TRAW | Traws Pharma, Inc. | 16.30M | -3.32% | 61,863 | 2.85M |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 15.77M | 2.65% | 404,449 | - |
| 498 | APLT | Applied Therapeutics, Inc. | 15.70M | 0.19% | 2,693,318 | 1.00M |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 15.62M | -3.88% | 54,408 | - |
| 500 | LIMN | Liminatus Pharma, Inc. | 15.46M | 3.80% | 89,514 | - |
| 501 | KALA | KALA BIO, Inc. | 14.90M | -0.47% | 276,111 | - |
| 502 | OSRH | OSR Holdings, Inc. | 14.35M | -4.26% | 1,414,908 | -90.52K |
| 503 | KAPA | Kairos Pharma, Ltd. | 13.90M | 0.47% | 91,167 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 13.60M | -1.32% | 112,596 | - |
| 505 | COCP | Cocrystal Pharma, Inc. | 13.51M | -0.02% | 202,798 | - |
| 506 | BLRX | BioLineRx Ltd. | 13.49M | -3.22% | 14,267 | 12.74M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 13.36M | -2.17% | 29,225 | - |
| 508 | BCDA | BioCardia, Inc. | 12.84M | -1.63% | 42,438 | 3.00K |
| 509 | MBRX | Moleculin Biotech, Inc. | 12.69M | -3.96% | 94,263 | - |
| 510 | NCEL | NewcelX Ltd. | 12.54M | 5.77% | 60,196 | - |
| 511 | SNGX | Soligenix, Inc. | 12.41M | -1.60% | 123,617 | 2.34K |
| 512 | TPST | Tempest Therapeutics, Inc. | 12.17M | -9.19% | 83,661 | - |
| 513 | LGVN | Longeveron Inc. | 11.69M | -2.07% | 245,894 | 1.44M |
| 514 | SNSE | Sensei Biotherapeutics, Inc. | 11.55M | -3.58% | 147,970 | - |
| 515 | BOLT | Bolt Biotherapeutics, Inc. | 11.48M | 1.36% | 29,211 | 5.20M |
| 516 | CRIS | Curis, Inc. | 11.27M | -2.90% | 138,972 | 11.65M |
| 517 | BCAB | BioAtla, Inc. | 11.00M | -35.58% | 13,819,270 | 11.00M |
| 518 | IMNN | Imunon, Inc. | 10.81M | -4.22% | 47,555 | - |
| 519 | NCNA | NuCana plc | 10.74M | 2.79% | 72,261 | - |
| 520 | AKTX | Akari Therapeutics, Plc | 10.73M | 1.02% | 174,979 | - |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 10.63M | -2.27% | 282,392 | - |
| 522 | GRDX | GridAI Technologies Corp. | 10.52M | - | 107,747 | - |
| 523 | CMMB | Chemomab Therapeutics Ltd. | 10.31M | 8.06% | 47,079 | - |
| 524 | EDSA | Edesa Biotech, Inc. | 10.25M | 5.13% | 618,714 | - |
| 525 | BRTX | BioRestorative Therapies, Inc. | 10.21M | 0.88% | 6,961 | 383.40K |
| 526 | QNCX | Quince Therapeutics, Inc. | 10.02M | 5.88% | 9,852,401 | - |
| 527 | GDTC | CytoMed Therapeutics Limited | 9.92M | 6.62% | 5,231 | 573.19K |
| 528 | ERNA | Ernexa Therapeutics Inc. | 9.73M | 1.64% | 26,057 | 1,000.00 |
| 529 | CALC | CalciMedica, Inc. | 9.65M | -25.56% | 2,274,767 | - |
| 530 | PHGE | BiomX Inc. | 9.51M | 8.92% | 140,394 | - |
| 531 | PULM | Pulmatrix, Inc. | 9.35M | -0.39% | 11,753 | 3.00K |
| 532 | BIVI | BioVie Inc. | 9.35M | 8.77% | 204,014 | - |
| 533 | ICU | SeaStar Medical Holding Corporation | 9.08M | 5.88% | 89,620 | 881.00K |
| 534 | EVGN | Evogene Ltd. | 8.96M | 0.99% | 34,476 | 8.02M |
| 535 | REVB | Revelation Biosciences, Inc. | 8.92M | -7.39% | 232,030 | - |
| 536 | KPRX | Kiora Pharmaceuticals, Inc. | 8.58M | -2.50% | 47,137 | 20.00K |
| 537 | RNAZ | TransCode Therapeutics, Inc. | 8.53M | -2.00% | 6,715 | - |
| 538 | PMCB | PharmaCyte Biotech, Inc. | 8.30M | - | 127,937 | - |
| 539 | ALZN | Alzamend Neuro, Inc. | 8.25M | 0.93% | 35,065 | - |
| 540 | XTLB | XTL Biopharmaceuticals Ltd. | 8.25M | -1.82% | 18,989 | 968.00K |
| 541 | IMRN | Immuron Limited | 7.70M | -3.12% | 13,422 | 4.78M |
| 542 | APVO | Aptevo Therapeutics Inc. | 7.52M | 3.71% | 94,520 | - |
| 543 | ADXN | Addex Therapeutics Ltd | 7.41M | -2.74% | 668 | 198.82K |
| 544 | MTVA | MetaVia Inc. | 7.41M | -4.94% | 828,807 | - |
| 545 | CELZ | Creative Medical Technology Holdings, Inc. | 7.27M | 2.97% | 25,521 | 6.00K |
| 546 | CLDI | Calidi Biotherapeutics, Inc. | 7.23M | -3.17% | 57,571 | - |
| 547 | APM | Aptorum Group Limited | 6.92M | -10.22% | 358,144 | - |
| 548 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.71M | 10.88% | 24,068 | - |
| 549 | PPBT | Purple Biotech Ltd | 6.62M | -1.21% | 117,984 | - |
| 550 | MBIO | Mustang Bio, Inc. | 6.53M | -7.24% | 107,316 | - |
| 551 | TOVX | Theriva Biologics, Inc. | 6.35M | -1.11% | 856,529 | - |
| 552 | VIVS | VivoSim Labs, Inc. | 6.34M | -16.78% | 1,416,922 | 140.00K |
| 553 | TCRT | Alaunos Therapeutics, Inc. | 6.14M | 4.56% | 12,758 | 6.00K |
| 554 | ADIL | Adial Pharmaceuticals, Inc. | 5.96M | 0.80% | 145,233 | - |
| 555 | PCSA | Processa Pharmaceuticals, Inc. | 5.95M | -12.50% | 173,810 | - |
| 556 | GNPX | Genprex, Inc. | 5.77M | -6.39% | 740,555 | - |
| 557 | CANF | Can-Fite BioPharma Ltd. | 5.68M | 2.99% | 23,529 | 560.00K |
| 558 | SLXN | Silexion Therapeutics Corp | 5.63M | -1.64% | 15,323 | - |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 5.59M | 0.63% | 53,615 | - |
| 560 | BGMS | Bio Green Med Solution, Inc. | 5.54M | -6.61% | 25,250 | 81.00K |
| 561 | GTBP | GT Biopharma, Inc. | 5.43M | -22.69% | 4,225,860 | - |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 5.25M | 1.47% | 106,435 | 2.86M |
| 563 | APRE | Aprea Therapeutics, Inc. | 5.25M | -5.68% | 2,390,772 | 488.24K |
| 564 | ABP | Abpro Holdings, Inc. | 5.22M | -0.52% | 30,105 | 183.00K |
| 565 | XBIO | Xenetic Biosciences, Inc. | 5.15M | 1.35% | 5,655 | 2.86M |
| 566 | DRMA | Dermata Therapeutics, Inc. | 4.82M | -10.22% | 636,798 | - |
| 567 | GOVX | GeoVax Labs, Inc. | 4.81M | - | 74,651 | 3.35M |
| 568 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.69M | -12.29% | 3,617,526 | 1.36M |
| 569 | DCOY | Decoy Therapeutics Inc. | 4.60M | -6.62% | 358,997 | - |
| 570 | ASBP | Aspire Biopharma Holdings, Inc. | 4.57M | -20.19% | 534,759 | 1.94K |
| 571 | INDP | Indaptus Therapeutics, Inc. | 4.51M | -8.64% | 47,405 | - |
| 572 | SILO | Silo Pharma, Inc. | 4.35M | -5.30% | 127,266 | 72.10K |
| 573 | ENVB | Enveric Biosciences, Inc. | 4.21M | 4.12% | 49,332 | - |
| 574 | GRI | GRI Bio, Inc. | 4.13M | -12.27% | 249,981 | - |
| 575 | ELAB | PMGC Holdings Inc. | 3.97M | -4.56% | 113,854 | 285.95K |
| 576 | MLEC | Moolec Science SA | 3.90M | -17.38% | 56,346 | 7.83M |
| 577 | PBM | Psyence Biomedical Ltd. | 3.88M | - | 5,055,616 | - |
| 578 | MTNB | Matinas BioPharma Holdings, Inc. | 3.85M | 0.45% | 16,390 | - |
| 579 | GLMD | Galmed Pharmaceuticals Ltd. | 3.65M | -6.28% | 90,628 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.59M | 13.48% | 89,499 | 600.00K |
| 581 | OGEN | Oragenics, Inc. | 3.58M | -0.04% | 27,910 | - |
| 582 | XRTX | XORTX Therapeutics Inc. | 3.54M | -1.18% | 47,375 | - |
| 583 | SCNI | Scinai Immunotherapeutics Ltd. | 3.36M | -1.02% | 8,836 | 1.15M |
| 584 | CNSP | CNS Pharmaceuticals, Inc. | 3.36M | -3.05% | 6,940 | - |
| 585 | SPRC | SciSparc Ltd. | 3.35M | 0.13% | 690,944 | 1.31M |
| 586 | CMND | Clearmind Medicine Inc. | 3.34M | 2.76% | 45,445 | - |
| 587 | ARTL | Artelo Biosciences, Inc. | 3.29M | -4.68% | 9,848 | - |
| 588 | PPCB | Propanc Biopharma, Inc. | 3.06M | 0.48% | 344,742 | - |
| 589 | HCWB | HCW Biologics Inc. | 3.03M | 0.90% | 65,906 | 422.03K |
| 590 | BBLG | Bone Biologics Corporation | 2.93M | -0.61% | 32,784 | - |
| 591 | JAGX | Jaguar Health, Inc. | 2.90M | -5.11% | 390,696 | 11.79M |
| 592 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.65M | -3.97% | 82,763 | 15.78K |
| 593 | AZTR | Azitra, Inc. | 2.63M | 0.04% | 937,222 | 7.50K |
| 594 | ENSC | Ensysce Biosciences, Inc. | 2.58M | -2.26% | 121,396 | 4.49M |
| 595 | ONCO | Onconetix, Inc. | 2.19M | -0.70% | 27,057 | 1.22M |
| 596 | VRAX | Virax Biolabs Group Limited | 2.02M | -3.89% | 121,087 | 2.99K |
| 597 | CDT | CDT Equity Inc. | 1.93M | 1.83% | 33,365 | - |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 1.43M | -3.95% | 104,354 | 104.90K |
| 599 | ADTX | Aditxt, Inc. | 1.42M | -2.33% | 218,188 | 5.95K |